2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Leukemia
24
Breast Neoplasms
20
Lymphoma
9
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Sarcoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Follicular
6
Leukemia, Myeloid, Acute
6
Precancerous Conditions
5
Multiple Myeloma
5
Head and Neck Neoplasms
5
Esophageal Neoplasms
5
Congenital Abnormalities
5
Colonic Neoplasms
5
Central Nervous System Neoplasms
5
Stomach Neoplasms
4
Ovarian Neoplasms
4
Lymphoma, Large-Cell, Anaplastic
4
Colorectal Neoplasms
4
Burkitt Lymphoma
4
Adenocarcinoma Of Esophagus
4
Wilms Tumor
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Osteosarcoma
3
Neuroectodermal Tumors, Primitive, Peripheral
3
Neuroblastoma
3
Interventions
Colposcopy
18
Imiquimod
14
Conization
12
Papillomavirus Vaccines
9
Vaccines
7
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
7
Cryotherapy
7
Biopsy
6
Acetic Acid
6
human papillomavirus vaccine, L1 type 16, 18
5
Vaginal Smears
5
Papanicolaou Test
5
Human Papillomavirus DNA Tests
5
Blood Specimen Collection
5
Watchful Waiting
4
GX-188 vaccine
4
Surveys and Questionnaires
3
Cisplatin
3
VGX-3100
2
Transurethral Resection of Prostate
2
Topotecan
2
Spectrometry, Fluorescence
2
Restraint, Physical
2
Proflavine
2
Polymerase Chain Reaction
2
Paclitaxel
2
Mass Screening
2
Indomethacin
2
Immunohistochemistry
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Dysplasia
×
Microarray Analysis
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled